Personalized treatment of Sézary syndrome by targeting a novel CTLA4:CD28 fusion.
Mol Genet Genomic Med
; 3(2): 130-6, 2015 Mar.
Article
in En
| MEDLINE
| ID: mdl-25802883
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Type of study:
Prognostic_studies
Language:
En
Journal:
Mol Genet Genomic Med
Year:
2015
Document type:
Article
Country of publication: